Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 206 of the 207 references it cites were found in a registry or an index, and 1 are not checked yet.

Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System

Open access
Melis, Maria Rosaria, Argiolas, Antonio · 2021 · Biomolecules

Abstract

Nitric oxide (NO), the neuromodulator/neurotransmitter formed from l-arginine by neuronal, endothelial and inducible NO synthases, is involved in numerous functions across the body, from the control of arterial blood pressure to penile erection, and at central level from energy homeostasis regulation to memory, learning and sexual behavior. The aim of this work is to review earlier studies showing that NO plays a role in erectile function and sexual behavior in the hypothalamus and its paraventricular nucleus and the medial preoptic area, and integrate these findings with those of recent studies on this matter. This revisitation shows that NO influences erectile function and sexual behavior in males and females by acting not only in the paraventricular nucleus and medial preoptic area but also in extrahypothalamic brain areas, often with different mechanisms. Most importantly, since these areas are strictly interconnected with the paraventricular nucleus and medial preoptic area, send to and receive neural projections from the spinal cord, in which sexual communication between brain and genital apparatus takes place, this review reveals that central NO participates in concert with neurotransmitters/neuropeptides to a neural circuit controlling both the consummatory (penile erection, copulation, lordosis) and appetitive components (sexual motivation, arousal, reward) of sexual behavior.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biom11121866

Cites

206 of 207 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A schematic representation of the neural pathways controlling the male and female genital apparatus. When sexual (visual, auditory, olfactory, tactile and even imaginative in humans) stimuli reach the brain high centers, this activates neural pathways, to date still unknown, leading to penile erection in males and clitoris erection and vaginal lubrication in females, allowing sexual intercourse. These pathways travel from the brain, mainly from the hypothalamus and its nuclei (paraventricular nucleus, ventromedial nucleus), and medial preoptic area, through the medulla oblongata and the spinal cord, to the genital apparatus. The latter is innervated by pudendal nerves originating from the sacral S2–S4 spinal tract and containing the primary afferent sensory from and motor pathways to the penis in the male and to the clitoris in the female, and by cavernous nerves containing the primary efferent sympathetic and parasympathetic pathways originating in the pelvic plexuses. These receive neural inputs from (i) pelvic nerves originating in the sacral S2–S4 spinal tract, (ii) hypogastric nerves originating in the thoracic-lumbar (T4-L2) spinal tract and (iii) post-ganglia fibers originating from the paravertebral sympathetic ganglia of the thoracic–lumbar tract of the spinal cord (T11-L2). Details are found in [15,16,17,40,53,54,56,57,59,60,63,64,65,67,68,75].
Figure 1 A schematic representation of the neural pathways controlling the male and female genital apparatus. When sexual (visual, auditory, olfactory, tactile and even imaginative in humans) stimuli reach the brain high centers, this activates neural pathways, to date still unknown, leading to penile erection in males and clitoris erection and vaginal lubrication in females, allowing sexual intercourse. These pathways travel from the brain, mainly from the hypothalamus and its nuclei (paraventricular nucleus, ventromedial nucleus), and medial preoptic area, through the medulla oblongata and the spinal cord, to the genital apparatus. The latter is innervated by pudendal nerves originating from the sacral S2–S4 spinal tract and containing the primary afferent sensory from and motor pathways to the penis in the male and to the clitoris in the female, and by cavernous nerves containing the primary efferent sympathetic and parasympathetic pathways originating in the pelvic plexuses. These receive neural inputs from (i) pelvic nerves originating in the sacral S2–S4 spinal tract, (ii) hypogastric nerves originating in the thoracic-lumbar (T4-L2) spinal tract and (iii) post-ganglia fibers originating from the paravertebral sympathetic ganglia of the thoracic–lumbar tract of the spinal cord (T11-L2). Details are found in [15,16,17,40,53,54,56,57,59,60,63,64,65,67,68,75].CC BY · PubMed Central
Figure 2 The main mechanism by which dopamine (DA) agonists of the D2 family (D2 and D4 receptor subtype), oxytocin, NMDA, hexarelin peptides and VGF peptides facilitate penile erection and copulatory activity in male rats is the activation of oxytocinergic neurons originating in the PVN and projecting to the spinal cord and to extrahypothalamic brain areas. Apparently all the above compounds, by acting on their own receptors localized in the cell bodies of these oxytocinergic neurons, increase Ca2+ ions influx in the cell bodies of these neurons, in turn causing the activation of NO synthase (NOS), the Ca2+ calmodulin-dependent enzyme present in oxytocinergic cell bodies that converts the amino acid l-arginine (l-Arg) to nitric oxide (NO). NO in turn activates oxytocinergic neurons to release oxytocin in the spinal cord and in extrahypothalamic brain areas inducing penile erection and facilitating sexual behavior by a mechanism not involving the guanylate cyclase-cyclic guanosine monophosphate (GC-cGMP) pathway, as discussed below (Section 2.4.2). PVN oxytocinergic neurons facilitate penile erection and sexual activity not only when activated by the above compounds, but also by drugs that increase PVN NO concentration (NO donors), by the blockade of PVN CB1 receptors (which are not located on oxytocinergic cell bodies but increase the activity of the latter ones by increasing glutamatergic neurotransmission in the PVN) (see Section 2.2.4/Figure 3), and by physiological sexual stimuli (e.g., pheromones and others). Conversely, when these oxytocinergic neurons are inhibited, for instance by gamma-amino-butyric acid GABA, opioid peptides/opiate drugs or by drugs that inhibit NOS activity, the spontaneous (i.e., physiologically activated) or drug/neuropeptide-stimulated erectile function and sexual activity is reduced. Details are found in [16,17,40,53,54,55,56,57,73,77,88,89,90,91,92,93,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116].
Figure 2 The main mechanism by which dopamine (DA) agonists of the D2 family (D2 and D4 receptor subtype), oxytocin, NMDA, hexarelin peptides and VGF peptides facilitate penile erection and copulatory activity in male rats is the activation of oxytocinergic neurons originating in the PVN and projecting to the spinal cord and to extrahypothalamic brain areas. Apparently all the above compounds, by acting on their own receptors localized in the cell bodies of these oxytocinergic neurons, increase Ca2+ ions influx in the cell bodies of these neurons, in turn causing the activation of NO synthase (NOS), the Ca2+ calmodulin-dependent enzyme present in oxytocinergic cell bodies that converts the amino acid l-arginine (l-Arg) to nitric oxide (NO). NO in turn activates oxytocinergic neurons to release oxytocin in the spinal cord and in extrahypothalamic brain areas inducing penile erection and facilitating sexual behavior by a mechanism not involving the guanylate cyclase-cyclic guanosine monophosphate (GC-cGMP) pathway, as discussed below (Section 2.4.2). PVN oxytocinergic neurons facilitate penile erection and sexual activity not only when activated by the above compounds, but also by drugs that increase PVN NO concentration (NO donors), by the blockade of PVN CB1 receptors (which are not located on oxytocinergic cell bodies but increase the activity of the latter ones by increasing glutamatergic neurotransmission in the PVN) (see Section 2.2.4/Figure 3), and by physiological sexual stimuli (e.g., pheromones and others). Conversely, when these oxytocinergic neurons are inhibited, for instance by gamma-amino-butyric acid GABA, opioid peptides/opiate drugs or by drugs that inhibit NOS activity, the spontaneous (i.e., physiologically activated) or drug/neuropeptide-stimulated erectile function and sexual activity is reduced. Details are found in [16,17,40,53,54,55,56,57,73,77,88,89,90,91,92,93,100,101,102,103,104,105,106,107,108,109,110,111,112,113,114,115,116].CC BY · PubMed Central
Figure 3 A synthetic representation of two possible mechanisms by means of which endocannabinoids may inhibit penile erection at the PVN level in male rats. Briefly, endocannabinoids inhibit the release of glutamic acid (GLU) from glutamatergic synapses impinging on the cell bodies of oxytocinergic neurons (OXY) by acting mainly on CB1 receptors located on these glutamatergic synapses; alternatively, they can act on CB1 receptors localized on inhibitory GABAergic synapses that impinge on these glutamatergic synapses and whose activation inhibits glutamic acid release. In both cases this causes a reduction in Ca2+ influx through Ca2+ channels-coupled NMDA receptors in the cell bodies of oxytocinergic neurons mediating penile erection followed by a reduction in NO synthase activity, thereby inhibiting oxytocinergic neurons and penile erection. The above mechanisms may also be not mutually exclusive and operate in concert to inhibit erectile function. Both these mechanisms have been identified in other brain areas rich in CB1 receptors. (+) = activation; (−) = inhibition. Details are found in [95,100,101,112,113].
Figure 3 A synthetic representation of two possible mechanisms by means of which endocannabinoids may inhibit penile erection at the PVN level in male rats. Briefly, endocannabinoids inhibit the release of glutamic acid (GLU) from glutamatergic synapses impinging on the cell bodies of oxytocinergic neurons (OXY) by acting mainly on CB1 receptors located on these glutamatergic synapses; alternatively, they can act on CB1 receptors localized on inhibitory GABAergic synapses that impinge on these glutamatergic synapses and whose activation inhibits glutamic acid release. In both cases this causes a reduction in Ca2+ influx through Ca2+ channels-coupled NMDA receptors in the cell bodies of oxytocinergic neurons mediating penile erection followed by a reduction in NO synthase activity, thereby inhibiting oxytocinergic neurons and penile erection. The above mechanisms may also be not mutually exclusive and operate in concert to inhibit erectile function. Both these mechanisms have been identified in other brain areas rich in CB1 receptors. (+) = activation; (−) = inhibition. Details are found in [95,100,101,112,113].CC BY · PubMed Central
Figure 4 NO influences penile erection by acting in several rat brain areas including the PVN, the ventral tegmental area, the ventral subiculum of the hippocampus, the posteromedial cortical nucleus of the amygdala and the bed nucleus of the stria terminalis. In these areas NO acts by means of different mechanisms. In the PVN, NO activates oxytocinergic neurons projecting to the spinal cord that mediate penile erection and to extrahypothalamic areas including the ventral tegmental area and the posteromedial cortical nucleus of the amygdala. Here, NO acts intracellularly in the neurons in which it is formed by a yet unknown mechanism unrelated to the guanylate cyclase-cGMP pathway. Additionally, in the ventral tegmental area (VTA), NO produced by the activation of NO synthase localized in the cell bodies of mesolimbic-mesocortical dopaminergic neurons acts intracellularly in the dopaminergic neurons in which is produced by the activation of oxytocinergic receptors that induce penile erection. However in these neurons, at variance from the PVN, NO activates guanylate cyclase to increase cGMP levels, which lead to the activation of dopaminergic neurons to release dopamine in the nucleus accumbens and in the medial prefrontal cortex and to induce penile erection. It is likely that a NO-cGMP pathway is also operative in the ventral subiculum (VS) and the posteromedial cortical nucleus of the amygdala (Am) in neurons activated by oxytocin given in these areas at a dose that induces penile erection. At variance from the ventral tegmental area, here NO acts after being released from the neurons in which is formed as an intercellular messenger to activate excitatory neurons projecting directly or indirectly to the ventral tegmental area in order to activate mesolimbic and mesocortical dopaminergic neurons to release dopamine in the nucleus accumbens and in the medial prefrontal cortex and induce penile erection. In the bed nucleus of the stria terminalis (BNST), oxytocin releases glutamic acid that acts on the cell bodies of glutamatergic neurons containing NO synthase and projecting to the PVN, ventral tegmental area, hippocampus and amygdala. How NO formed in the bed nucleus acts to facilitate erectile function is still unknown. Details are found in [47,48,49,50,51,53,54,55,56,57,96,97,98,99,143,144,151,152,160].
Figure 4 NO influences penile erection by acting in several rat brain areas including the PVN, the ventral tegmental area, the ventral subiculum of the hippocampus, the posteromedial cortical nucleus of the amygdala and the bed nucleus of the stria terminalis. In these areas NO acts by means of different mechanisms. In the PVN, NO activates oxytocinergic neurons projecting to the spinal cord that mediate penile erection and to extrahypothalamic areas including the ventral tegmental area and the posteromedial cortical nucleus of the amygdala. Here, NO acts intracellularly in the neurons in which it is formed by a yet unknown mechanism unrelated to the guanylate cyclase-cGMP pathway. Additionally, in the ventral tegmental area (VTA), NO produced by the activation of NO synthase localized in the cell bodies of mesolimbic-mesocortical dopaminergic neurons acts intracellularly in the dopaminergic neurons in which is produced by the activation of oxytocinergic receptors that induce penile erection. However in these neurons, at variance from the PVN, NO activates guanylate cyclase to increase cGMP levels, which lead to the activation of dopaminergic neurons to release dopamine in the nucleus accumbens and in the medial prefrontal cortex and to induce penile erection. It is likely that a NO-cGMP pathway is also operative in the ventral subiculum (VS) and the posteromedial cortical nucleus of the amygdala (Am) in neurons activated by oxytocin given in these areas at a dose that induces penile erection. At variance from the ventral tegmental area, here NO acts after being released from the neurons in which is formed as an intercellular messenger to activate excitatory neurons projecting directly or indirectly to the ventral tegmental area in order to activate mesolimbic and mesocortical dopaminergic neurons to release dopamine in the nucleus accumbens and in the medial prefrontal cortex and induce penile erection. In the bed nucleus of the stria terminalis (BNST), oxytocin releases glutamic acid that acts on the cell bodies of glutamatergic neurons containing NO synthase and projecting to the PVN, ventral tegmental area, hippocampus and amygdala. How NO formed in the bed nucleus acts to facilitate erectile function is still unknown. Details are found in [47,48,49,50,51,53,54,55,56,57,96,97,98,99,143,144,151,152,160].CC BY · PubMed Central
Figure 5 A hypothetical mechanism to explain how NO facilitates penile reflexes and copulation in male rats by increasing dopamine release in the medial preoptic area induced by glutamic acid released from glutamatergic synapses of neurons originating in the amygdala and in the bed nucleus of the stria terminalis activated by sexual stimuli (e.g., those produced by a sexually receptive female rat) and controlling dopamine release from incertohypothalamic dopaminergic neurons. Briefly, NO—once formed by yet unidentified neurons/cells in the medial preoptic area—is released in the extracellular space and acts as a retrograde intercellular messenger on (i) dopaminergic synapses to potentiate dopamine release and facilitate copulation, and (ii) glutamatergic synapses to sustain glutamic acid release facilitating dopamine release, by activating a NO-cGMP signaling pathway. NO may also facilitate dopamine release from dopaminergic synapses by inhibiting the dopamine transporter (DAT), thus allowing dopamine to persist in the extracellular space and act for longer times on its receptors. (+) = activation; (-) = inhibition; (???) = unknown neurotransmitters. Details are found in [38,39,44,45,175,176,177,178,179,180,181,182,183,184,185].
Figure 5 A hypothetical mechanism to explain how NO facilitates penile reflexes and copulation in male rats by increasing dopamine release in the medial preoptic area induced by glutamic acid released from glutamatergic synapses of neurons originating in the amygdala and in the bed nucleus of the stria terminalis activated by sexual stimuli (e.g., those produced by a sexually receptive female rat) and controlling dopamine release from incertohypothalamic dopaminergic neurons. Briefly, NO—once formed by yet unidentified neurons/cells in the medial preoptic area—is released in the extracellular space and acts as a retrograde intercellular messenger on (i) dopaminergic synapses to potentiate dopamine release and facilitate copulation, and (ii) glutamatergic synapses to sustain glutamic acid release facilitating dopamine release, by activating a NO-cGMP signaling pathway. NO may also facilitate dopamine release from dopaminergic synapses by inhibiting the dopamine transporter (DAT), thus allowing dopamine to persist in the extracellular space and act for longer times on its receptors. (+) = activation; (-) = inhibition; (???) = unknown neurotransmitters. Details are found in [38,39,44,45,175,176,177,178,179,180,181,182,183,184,185].CC BY · PubMed Central
Figure 6 Nitric oxide produced by NO synthase (NOS) participates in a complex neural circuit that controls sexual motivation, reward and performance at central level together with other neurotransmitters and neuropeptides. This circuit interconnects the hypothalamus and its nuclei (paraventricular and ventromedial) with limbic areas (ventral tegmental area, hippocampus, amygdala, bed nucleus of the stria terminalis) and with the ventral medulla and spinal cord. Among neural pathways involved are (i) PVN oxytocinergic neurons that send their projections to the ventral medulla and spinal cord, and to the ventral tegmental area, hippocampus, amygdala and bed nucleus of the stria terminalis; (ii) mesolimbic/mesocortical dopaminergic neurons originating in the ventral tegmental area that send projections to the nucleus accumbens, medial prefrontal cortex, bed nucleus of the stria terminalis, hippocampus and amygdala; (iii) glutamatergic neurons that interconnect the hippocampus and the amygdala with the ventral tegmental area, prefrontal cortex, bed nucleus of the stria terminalis, medial preoptic area and PVN; (iv) neurons that project from the ventromedial nucleus of the hypothalamus to the periaqueductal gray matter and from here to the spinal cord (dashed lines), which control lordosis in estrous females and whose activity is modulated by different brain areas (medial preoptic area, ventral tegmental area, lateral septum). When this circuit is activated by physiological stimuli (i.e., pheromones released by sexually receptive females in males or by sexually potent males in females and/or other sexual stimuli) or by drugs or peptides given in one of the areas of the circuit, NO becomes involved at different sites, i.e., in the paraventricular and ventromedial nuclei and medial preoptic area, which are involved more in sexual performance (penile erection and copulation in males, lordosis in females), and the ventral tegmental area, hippocampus, amygdala and bed nucleus of the stria terminalis, which act on mesolimbic/mesocortical dopaminergic neurons that control sexual motivation, arousal and reward (light blue boxes indicate the brain areas of the circuit containing NO synthase). Thus, changes in NO activity in these brain areas participate in the modulation of both sexual motivation/arousal/reward and sexual performance (erectile function/lordosis/copulation). (?) = unknown neurotransmitters/neuropeptides. Details are found in [4,16,17,26,47,49,53,54,55,56,57,64,65,66,67,68,69,70,96,97,98,99,104,143,144,151,152,160,174,179,183,184,185,190,192,193,194] and references therein.
Figure 6 Nitric oxide produced by NO synthase (NOS) participates in a complex neural circuit that controls sexual motivation, reward and performance at central level together with other neurotransmitters and neuropeptides. This circuit interconnects the hypothalamus and its nuclei (paraventricular and ventromedial) with limbic areas (ventral tegmental area, hippocampus, amygdala, bed nucleus of the stria terminalis) and with the ventral medulla and spinal cord. Among neural pathways involved are (i) PVN oxytocinergic neurons that send their projections to the ventral medulla and spinal cord, and to the ventral tegmental area, hippocampus, amygdala and bed nucleus of the stria terminalis; (ii) mesolimbic/mesocortical dopaminergic neurons originating in the ventral tegmental area that send projections to the nucleus accumbens, medial prefrontal cortex, bed nucleus of the stria terminalis, hippocampus and amygdala; (iii) glutamatergic neurons that interconnect the hippocampus and the amygdala with the ventral tegmental area, prefrontal cortex, bed nucleus of the stria terminalis, medial preoptic area and PVN; (iv) neurons that project from the ventromedial nucleus of the hypothalamus to the periaqueductal gray matter and from here to the spinal cord (dashed lines), which control lordosis in estrous females and whose activity is modulated by different brain areas (medial preoptic area, ventral tegmental area, lateral septum). When this circuit is activated by physiological stimuli (i.e., pheromones released by sexually receptive females in males or by sexually potent males in females and/or other sexual stimuli) or by drugs or peptides given in one of the areas of the circuit, NO becomes involved at different sites, i.e., in the paraventricular and ventromedial nuclei and medial preoptic area, which are involved more in sexual performance (penile erection and copulation in males, lordosis in females), and the ventral tegmental area, hippocampus, amygdala and bed nucleus of the stria terminalis, which act on mesolimbic/mesocortical dopaminergic neurons that control sexual motivation, arousal and reward (light blue boxes indicate the brain areas of the circuit containing NO synthase). Thus, changes in NO activity in these brain areas participate in the modulation of both sexual motivation/arousal/reward and sexual performance (erectile function/lordosis/copulation). (?) = unknown neurotransmitters/neuropeptides. Details are found in [4,16,17,26,47,49,53,54,55,56,57,64,65,66,67,68,69,70,96,97,98,99,104,143,144,151,152,160,174,179,183,184,185,190,192,193,194] and references therein.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 207 references

Research works printed but not linked: 7

  1. Knobil, E., and Neil, J. (1994). The physiology of male sexual behavior. The Physiology of Reproduction, Raven Press.
  2. Pfaff, D.W., Arnold, A.P., Etgen, A.M., Fahrbach, S.E., and Rubin, R.T. (2002). Male sexual behavior. Hormones, Brain and Behavior, Academic Press.
  3. Rall, T.W., Nies, A.S., and Taylor, T. (1990). Drugs used for the treatment of angina: Organic nitrates, calcium channels blockers and B-adrenergic antagonists. Goodman and Gilman’s The Pharmacological Basis of Therapeutic, Pergamon Press.
  4. Sandler, M., and Gessa, G.L. (1975). Amy1 nitrite (“Poppers”) as an aphrodisiac. Sexual Behavior—Pharmacology and Biochemistry, Raven Press.
  5. Ignarro, 1992, Nitric oxide as the physiological mediator of penile erection, J. NIH Res., 4, 59
  6. Knobil, E., and Neil, J.D. (1994). Cellular and molecular mechanisms of female reproductive behaviors. The Physiology of Reproduction, Raven Press. [2nd ed.].
  7. Plant, T., and Zeleznik, A. (2015). Female sexual behavior. Knobil and Neill’s Physiology of Reproduction, Academic Press. [4th ed.].

Cited by

See all 49

Metadata

Authors
Melis, M. R., & Argiolas, A.
Affiliations
University of Cagliari (IT)
Corresponding author
Melis, Maria Rosaria
Venue
Biomolecules
Publisher
MDPI AG
Published
2021-12-11
Volume
11
Issue
12
Pages
1866
ISSN
2218-273X (ISSN-L)
OpenAlex
W4200537599
Cited by
47
References
207
Citations by year
2026: 10 · 2025: 13 · 2024: 15 · 2023: 4 · 2022: 5
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • Biomolecules (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
Funders
Department of Biomedical Sciences, University of Cagliari (FIR 2015-2020)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
nitric oxide, erectile function, sexual behavior, hypothalamus, paraventricular nucleus, medial preoptic area, nitric oxide synthase, L-arginine, sexual motivation, sexual arousal, sexual reward, lordosis, copulation, neural circuits, neurotransmitters, neuropeptides
MeSH terms
Animals, Arginine, Central Nervous System, Female, Humans, Male, Nitric Oxide, Penile Erection, Sexual Behavior, Nitric Oxide Synthase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System. https://app.cochat.ai/papers/10.3390/biom11121866
The paper
Melis, M. R., & Argiolas, A. (2021). Erectile Function and Sexual Behavior: A Review of the Role of Nitric Oxide in the Central Nervous System. Biomolecules. https://doi.org/10.3390/biom11121866

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.